The vaccination against Ebola of high-risk populations began on Monday in Côte d’Ivoire following the discovery of an outbreak in the country three days ago. The swift response came after vaccines manufactured by Merck, which the World Health Organization (WHO) helped to secure to fight a four-month long outbreak in neighbouring Guinea, were quickly sent to the country.
BRAZIL: ‘Resistance Is Intergenerational, and Art Is How Energy Gets Renewed’ 
The Dollar-Gold Standard’s Lingering Demise 
The Global Leaders Network Pushes to Protect Women’s and Children’s Health 
The Takeaway: UN General Assembly debate Day 5 
Lavrov issues call for new Eurasian ‘security architecture’ 
Cuba warns against ‘law of the jungle’ as Foreign Minister denounces US pressure